Browse our 650+ Publications​

Latest Publications

EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity

Jing R, et al.
Cell Stem Cell
August 2022
Authors and Affiliates
Ran Jing 1, Irene Scarfo 2, Mohamad Ali Najia 3, Edroaldo Lummertz da Rocha 4, Areum Han 1, Michael Sanborn 5, Trevor Bingham 5, Caroline Kubaczka 1, Deepak K Jha 1, Marcelo Falchetti 6, Thorsten M Schlaeger 7, Trista E North 8, Marcela V Maus 2, George Q Daley 9; 1 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. 2 Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. 3 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard-MIT Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. 4 Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil. 5 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA. 6 Graduate Program of Pharmacology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil. 7 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. 8 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA. 9 Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA. Electronic address: george.daley@childrens.harvard.edu.

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

Lyudovyk O, et al.
Cancer Cell
August 2022
Authors and Affiliates
Olga Lyudovyk 1, Justin Y Kim 2, David Qualls 3, Madeline A Hwee 4, Ya-Hui Lin 4, Sawsan R Boutemine 5, Yuval Elhanati 1, Alexander Solovyov 1, Melanie Douglas 3, Eunise Chen 6, N Esther Babady 7, Lakshmi Ramanathan 8, Pallavi Vedantam 9, Chaitanya Bandlamudi 9, Sigrid Gouma 10, Philip Wong 9, Scott E Hensley 11, Benjamin Greenbaum 12, Alexander C Huang 13, Santosha A Vardhana 14; 1 Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2 Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 3 Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4 Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 5 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 6 University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA. 7 Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 8 Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 9 Memorial Sloan Kettering Cancer Center, New York, NY, USA. 10 Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 11 Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 12 Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Physiology, Biophysics & Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: greenbab@mskcc.org. 13 Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: alexander.huang@pennmedicine.upenn.edu. 14 Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: vardhans@mskcc.org.

Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5 hi PD-1 hi T follicular helper cells

Yeh C, et al.
Immunity
August 2022
Authors and Affiliates
Chen-Hao Yeh 1, Joel Finney 1, Takaharu Okada 2, Tomohiro Kurosaki 3, Garnett Kelsoe 4; 1 Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA. 2 Laboratory for Tissue Dynamics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Kanagawa 230-0045, Japan; Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa 230-0045, Japan. 3 Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan; Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Kanagawa 230-0045, Japan. 4 Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery and Duke University Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: ghkelsoe@duke.edu.

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

Schad SE, et al.
Journal of Experimental Medicine
August 2022
Authors and Affiliates
Sara E Schad 1,2, Andrew Chow 1,3, Levi Mangarin 1, Heng Pan 2,4, Jiajia Zhang 5,6, Nicholas Ceglia 7, Justina X Caushi 5,6, Nicole Malandro 1,2, Roberta Zappasodi 1,2, Mathieu Gigoux 1, Daniel Hirschhorn 1, Sadna Budhu 1, Masataka Amisaki 8, Monica Arniella 9, David Redmond 2, Jamie Chaft 3, Patrick M Forde 5,6, Justin F Gainor 10, Matthew D Hellmann 3, Vinod Balachandran 1,3,8,11, Sohrab Shah 7, Kellie N Smith 5,6, Drew Pardoll 5,6, Olivier Elemento 2,4, Jedd D Wolchok 1,2,3,12, Taha Merghoub 1,2,3,12; 1 Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY. 2 Weill Cornell Medical College, New York, NY. 3 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. 4 Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY. 5 John Hopkins University School of Medicine, Baltimore, MD. 6 Bloomberg-Kimmel Institute for Cancer Immunotherapy at John Hopkins, Baltimore, MD. 7 Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. 8 Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY. 9 Broad Institute of MIT and Harvard, Cambridge, MA. 10 Department of Medicine, Massachusetts General Hospital, Boston, MA. 11 Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 12 Human Oncology Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Alvarez-Breckenridge C, et al.
Cancer Immunology Research
August 2022
Authors and Affiliates
Christopher Alvarez-Breckenridge #,1,2, Samuel C Markson #,3,4,5,6, Jackson H Stocking 7, Naema Nayyar 7, Matt Lastrapes 5,6,8, Matthew R Strickland 7,9, Albert E Kim 7,9, Magali de Sauvage 7, Ashish Dahal 7, Juliana M Larson 7, Joana L Mora 5,6,9, Andrew W Navia 10,11,12,13, Robert H Klein 7, Benjamin M Kuter 7, Corey M Gill 7, Mia Bertalan 7, Brian Shaw 7, Alexander Kaplan 7, Megha Subramanian 7, Aarushi Jain 7, Swaminathan Kumar 14, Husain Danish 15,16, Michael White 7, Osmaan Shahid 6, Kristen E Pauken 3,4, Brian C Miller 3,4,5,17, Dennie T Frederick 18, Christine Hebert 19, McKenzie Shaw 19, Maria Martinez-Lage 19, Matthew Frosch 20, Nancy Wang 7, Elizabeth Gerstner 9, Brian V Nahed 2, William T Curry 2, Bob Carter 2, Daniel P Cahill 2, Genevieve Marie Boland 18, Benjamin Izar 21,22, Michael A Davies 14, Arlene H Sharpe 3,4,5, Mario L Suvà 5,19, Ryan J Sullivan 7,9, Priscilla K Brastianos #,5,7,9, Scott L Carter #,5,6; 1 Departments of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2 Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts. 3 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. 4 Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts. 5 Broad Institute, Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts. 6 Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. 7 Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts. 8 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 9 Massachusetts General Hospital Cancer Center, Boston, Massachusetts. 10 Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts. 11 Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, Massachusetts. 12 Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. 13 Ragon Institute, Harvard University, Massachusetts Institute of Technology, and Massachusetts General Hospital, Cambridge, Massachusetts. 14 Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 15 Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York. 16 Weill Cornell Medical Center, New York, New York. 17 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 18 Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 19 Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 20 C. S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 21 Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York. 22 Columbia Center for Translational Immunology, New York, New York. # Contributed equally.

Sensory nerves impede the formation of tertiary lymphoid structures and development of protective anti-melanoma immune responses

Vats K, et al.
Cancer Immunology Research
August 2022
Authors and Affiliates
Kavita Vats 1, Oleg Kruglov 2, Bikram Sahoo 3, Vishal Soman 1, Jiying Zhang 4, Galina V Shurin 5, Uma R Chandran 6, Pavel Skums 7, Michael R Shurin 5, Alex Zelikovsky 8, Walter J Storkus 6, Yuri L Bunimovich 6; 1 University of Pittsburgh, United States. 2 University of Pittsburgh, Pittsburgh, United States. 3 Georgia State University, Atlanta, Georgia, United States. 4 University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. 5 University of Pittsburgh Medical Center, Pittsburgh, PA, United States. 6 University of Pittsburgh, Pittsburgh, PA, United States. 7 Georgia State University, Atlanta, GA, United States. 8Georgia State University, Atlanta, Ga, United States.

Durable response in a patient with recurrent respiratory papillomatosis treated with immune checkpoint blockade

Bai K, et al.
Head & Neck
August 2022
Authors and Affiliates
Ke Bai 1, Scott M Norberg 2, Cem Sievers 1, Tanya Meyer 3, Jay Friedman 1, Christian Hinrichs 4, Clint T Allen 1; 1 Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA. 2 Genitourinary Malignancies Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA. 3 Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA. 4 Rutgers Cancer Center, New Brunswick, New Jersey, USA.

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Luoma AM, et al.
Cell
August 2022
Authors and Affiliates
Adrienne M Luoma 1, Shengbao Suo 2, Yifan Wang 3, Lauren Gunasti 4, Caroline B M Porter 5, Nancy Nabilsi 3, Jenny Tadros 3, Andrew P Ferretti 3, Sida Liao 3, Cagan Gurer 3, Yu-Hui Chen 6, Shana Criscitiello 4, Cora A Ricker 7, Danielle Dionne 5, Orit Rozenblatt-Rosen 5, Ravindra Uppaluri 8, Robert I Haddad 7, Orr Ashenberg 5, Aviv Regev 9, Eliezer M Van Allen 7, Gavin MacBeath 3, Jonathan D Schoenfeld 10, Kai W Wucherpfennig 11; 1 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA. 2 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Guangzhou Laboratory, Guangzhou, Guangdong 510005, China. Electronic address: suo_shengbao@gzlab.ac.cn. 3 TScan Therapeutics, Waltham, MA 02451, USA. 4 Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA 02115, USA. 5 Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. 6 Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA. 7 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. 8 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA. 9 Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. 10 Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: jonathan_schoenfeld@dfci.harvard.edu. 11 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: kai_wucherpfennig@dfci.harvard.edu.

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

Campisi L, et al.
Nature
August 2022
Authors and Affiliates
Laura Campisi 1, Shahab Chizari 2,3, Jessica S Y Ho 4, Anastasia Gromova 5,6,7,8, Frederick J Arnold 5,6,7,8, Lorena Mosca 9, Xueyan Mei 10, Yesai Fstkchyan 4, Denis Torre 11,12,13, Cindy Beharry 4, Marta Garcia-Forn 14,15,16,17, Miguel Jiménez-Alcázar 18, Vladislav A Korobeynikov 19, Jack Prazich 2,3, Zahi A Fayad 10, Marcus M Seldin 20, Silvia De Rubeis 14,15,16,17, Craig L Bennett 5,6,7,8, Lyle W Ostrow 21, Christian Lunetta 22,23, Massimo Squatrito 18, Minji Byun 24, Neil A Shneider 25, Ning Jiang 2,3, Albert R La Spada 26,27,28,29, Ivan Marazzi 30,31,32; 1 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. laura.campisi@mssm.edu. 2 Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. 3 Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA. 4 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5 Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA. 6 Department of Neurology, University of California, Irvine, Irvine, CA, USA. 7 Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA. 8 UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA. 9 Medical Genetics Unit, Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. 10 BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 11 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 12 Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 13 Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 14 Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 15 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 16 The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 17 Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 18 Seve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain. 19 Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. 20 Department of Biological Chemistry, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, CA, USA. 21 Neuromuscular Division of the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 22 NEMO Clinical Center, Fondazione Serena Onlus, Milan, Italy. 23 Neurorehabilitation Department, Istituti Clinici Scientifici Maugeri, IRCCS, Milan, Italy. 24 Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 25 Department of Neurology, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA. 26 Department of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu. 27 Department of Neurology, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu. 28 Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu. 29 UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu. 30 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu. 31 Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu. 32 Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.

A multi-omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti-PD1 response in solid tumors

Kumar N, et al.
August 2022
Authors and Affiliates
Namit Kumar 1, Simon Papillon-Cavanagh 1, Hao Tang 1, Shiliang Wang 1, Caitlyn Stromko 1, Ching-Ping Ho 1, Sonal Soni-Sheth 1, Steven Vasquez-Grinnell 1, Miranda L Broz 1, Daniel J Tenney 1, Michael J Wichroski 1, Alice M Walsh 1, Yanhua Hu 1, Joseph L Benci 1; 1 Bristol Myers Squibb: Research & Early Development, Princeton, New Jersey, USA.